Abstract
Objectives: Elderly patients with ovarian cancer represent a vulnerable population that frequently demonstrates poor outcomes. In this study, we sought to evaluate the impact of treatment modification (dose delays and reduction) on overall survival in the elderly as well as to characterize treatment patterns in this population and how they relate to overall survival (OS).
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
